Answers are grounded in this paper and cite their sources.
Cross-coupling reactions to form C(sp2)–C(sp3) bonds are becoming increasingly common in medicinal chemistry. Few studies have attempted to systematically compare these methodologies, making it difficult to choose first-pass reaction conditions on a complex system, especially when starting material is limited. Additionally, different alkyl building block classes have differing availabilities, costs, and chemical space coverage, which have implications in both medicinal and process chemistry. To fill this gap, the current study describes the development of a Variety Pack containing 12 C(sp2)–C(sp3) cross-coupling methodologies to quickly identify the optimal reaction for a specific aryl core. The reaction conditions were optimized to enable the rapid and convenient setup of all 12 reactions in parallel, as well as for long-term storage of the reagent mixtures for future use, which has allowed for broader adoption of these methodologies in our laboratories. The Variety Pack was applied to a diverse set of aryl bromides, alkyl building blocks, and drug-like informer molecules with high hit rates in all cases. High-yielding conditions from the set were directly applied to parallel libraries, demonstrating the immediate utility of the hits that were found. In cases where product was not formed in satisfactory yield, the highest yielding reaction served as a starting point for high-throughput experimentation campaigns where higher yielding conditions were found.
No takes yet. Share an insight, caveat, or question.
Diccianni et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: